Drug
Cdx 585
Cdx 585: highest development phase Phase 1, developed by Celldex Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Celldex Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| CDX-585 NCT05788484 | Phase 1 | Non-small Cell Lung Cancer |
Latest
No recent events.
Follow Cdx 585 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.